Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Quercetin may help with PCOS symptoms, but more research is needed.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Prolactin may be important for skin growth and immune function.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride effectively treats male hair loss, improving growth and density.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Finasteride doesn't affect bone density in male rats.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.